FDA approves Mass. company’s chemo-easing drug
The Food and Drug Administration has approved a chemo sickness drug made by a Waltham company.
The drug, Varubi, was green-lighted after four trials on patients receiving chemotherapy, according to a press release from manufacturer Tesaro. Studies showed the drug reduced vomiting, nausea, and retching in those who’d recently undergone the the harsh cancer treatment.
Up to 50 percent of patients undergoing highly or moderately emetogenic chemotherapy experience delayed nausea and vomiting, according to the company.
Last month, Boston Business Journal reported that Tesaro had begun a hiring spree in anticipation of the drug earning federal approval. According to the report, the company has doubled in the last year, growing from 100 employees at the end of 2014 to over 200 in August of 2015. Tesaro expects to add another 100 workers by the end of the year.
The drug could soon be in use at hospitals across the country, including right here in Massachusetts:
[bdc-gallery id=”110576″]
To comment, please create a screen name in your profile
To comment, please verify your email address
Conversation
This discussion has ended. Please join elsewhere on Boston.com